Abstract Background 5-aminosalicylic acid (5-ASA) is widely used for the treatment of inflammatory bowel disease (IBD), while its anti-inflammatory mechanisms remain controversial. The intestinal microbiota plays a certain role in pathogenesis IBD. We hypothesised that 5-ASA exerts effects by altering gut microbiota. Elucidating on and contribution to can lead development effective economical I...